EKITE 2 期:一个有价值的易于获取的资源,用于对血栓形成和华法林抗凝治疗的患者教育
Mary Bauman1, Rukhmi Bhat2, Reider Hagtvedt3
1Department of Pediatrics, The University of Alberta, Edmonton, Canada; KidClot Program, Stollery Children's Hospital, Alberta Health Services, Edmonton, Canada.
Thrombosis research
|May 3, 2025
概括
电子 KidClot 交互式血栓友爱教育 (eKITE) 华法林计划有效地改善了长期抗凝治疗儿童的知识和生活质量. 这项基于网络的培训增强了患者对华法林的理解和管理,从而减少了焦虑和改善了健康结果.
科学领域:
- 儿科血液学 儿科血液学
- 血栓友爱症管理管理
- 数字健康教育 数字健康教育
背景情况:
- 长期抗凝治疗 (LTA) 需要持续的患者和家庭知识,以有效管理.
- 儿童和家庭在理解和遵守LTA,包括常规监测方面经常面临挑战.
- 保持患者的参与和知识对于安全有效的抗凝治疗至关重要.
研究的目的:
- 评估电子 KidClot 交互式血栓友爱教育 (eKITE) 沃法林网络培训模块的有效性.
- 评估eKITE对抗凝血知识对长期服用华法林的儿童及其家属的影响.
- 确定 eKITE 是否作为常规临床随访的一部分增强了知识.
主要方法:
- 使用eKITE华法林系列作为华法林患者年度需求的前性研究.
- 患者进行了家庭INR测试或实验室测试;访问了在线教育模块和小题.
- 评估知识,学习偏好,与华法林管理相关的焦虑以及与健康有关的生活质量 (HrQOL).
主要成果:
- 共有136名儿童参与;79%的儿童在家中进行了INR测试.
- 平均知识分数从入学6个月后的84分提高到入学18个月后的90分.
- 治疗范围中的时间保持稳定;与学习相关的压力减少,HRQOL改善.
结论:
- eKITE是一系列实用,经济高效,易于使用的在线血栓形成和抗凝药的教育系列.
- 该计划支持增强知识,并改善治疗华法林的儿科患者的健康相关生活质量.
- eKITE为儿童和家庭管理抗凝血疗法提供了易于获得的资源.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
583
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
583
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.1K
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
436
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
436
Clinical Trials: Overview
2.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.6K
Drug Administration and Therapy Phases: Overview
397
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
397


